LATEST

• BUSINESS Asahi Kasei Banks on Tarpeyo to Hit 300 Billion Yen in Pharma Sales by FY2030
  March 26, 2026

• BUSINESS Takeda Unveils Annual 200 Billion Yen Cost Savings by FY2028
  March 26, 2026

• BUSINESS SanBio Targets Akuugo Shipments after May NHI Listing
  March 26, 2026

• BUSINESS Tracleer Generics Add Digital Ulcer Prevention Use
  March 26, 2026

• REGULATORY AMED Warns Projects without Japan Return May Miss Startup Funding
  March 26, 2026

• BUSINESS Generic Makers Win Pediatric Dosing Approval for Azilva Copies
  March 26, 2026

• BUSINESS Nippon Kayaku’s Humira Biosimilar Adds Pediatric UC Use
  March 26, 2026

• BUSINESS Kyorin Inks Sirturo Commercial Deal with J&J in Japan
  March 26, 2026

• BUSINESS Ono Sets Course for Growth Beyond Opdivo Patent Cliff
  March 25, 2026

• BUSINESS Fuji, Richter Strike Co-Development Pact in Women’s Health
  March 25, 2026

• REGULATORY Japan Cabinet Approves National MCM Strategy to Boost Pandemic Response
  March 25, 2026

• ORGANIZATION BCG’s Takeda Questions Conditional Pricing for Regenerative Medicines
  March 25, 2026

• ACADEMIA Real-World Study Backs Lecanemab Safety, 90% Stay on Treatment
  March 25, 2026

• BUSINESS ASKA Inks AI Target Discovery Pact with Insilico in Women’s Health
  March 25, 2026

• REGULATORY Pharma Urges Govt Support as Iran War Shows Early Impact on Supply Chains
  March 25, 2026

• BUSINESS Shionogi to Fully Acquire Sleep Disorder JV SASS
  March 25, 2026

• BUSINESS Stella Pharma Files Steboronine for Angiosarcoma
  March 25, 2026

• BUSINESS Kyorin Bags Global Rights to UBE’s Early-Stage Asset
  March 25, 2026

• ORGANIZATION Industry Groups Push Mindset Shift to Streamline Japan’s Clinical Trials
  March 24, 2026

• COMMENTARY A “Core Industry” in Name Only? Drug Pricing Reform Leaves a Sour Taste
  March 24, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• Next ›
• 最終 »